Mumps in Poland in 2019.
2019
Poland
epidemiology
mumps
Journal
Przeglad epidemiologiczny
ISSN: 0033-2100
Titre abrégé: Przegl Epidemiol
Pays: Poland
ID NLM: 0413725
Informations de publication
Date de publication:
2021
2021
Historique:
entrez:
26
10
2021
pubmed:
27
10
2021
medline:
28
10
2021
Statut:
ppublish
Résumé
Mumps is a highly infectious viral disease, the source of infection is an infected person. In 2003, compulsory vaccination against mumps was introduced in Poland, carried out according to a two-dose schedule. The combined MMR vaccine (against measles, mumps and rubella) is used as part of the Protective Vaccination Program (PVP). Mumps vaccination has led to a significant reduction in the incidence of mumps in Poland. The aim of the study was to evaluate the epidemiological indicators of mumps in Poland in 2019 compared to previous years. The analysis of the epidemiological situation of mumps in Poland in 2019 was based on the interpretation of data from the bulletin "Infectious diseases and poisonings in Poland in 2019" and "Vaccinations in Poland in 2019". In 2019, 1,338 mumps cases were registered in Poland. The total incidence was 3.5 per 100,000 inhabitants and was lower compared to 2018. The highest incidence 4.6 per 100,000 inhabitants were registered in the Opolskie Voivodeship and the lowest - 2.5 in the Podkarpackie Voivodeship. The incidence was the highest among 6-year-olds and amounted to 32.3/100,000. Comparing the differences between the sexes, the incidence of men (4.1/100,000) was higher than that of women (2.9). In 2019, 22 patients were hospitalized due to mumps in Poland, which was less than in 2018 (28). The level of mumps vaccination in children at 3 years of age was lower by 0.3% compared to 2018 and amounted to 92.6% in Poland. Maintaining a high percentage of children vaccinated against mumps will provide sustaining decline in cases of mumps in the coming years.
Sections du résumé
BACKGROUND
BACKGROUND
Mumps is a highly infectious viral disease, the source of infection is an infected person. In 2003, compulsory vaccination against mumps was introduced in Poland, carried out according to a two-dose schedule. The combined MMR vaccine (against measles, mumps and rubella) is used as part of the Protective Vaccination Program (PVP). Mumps vaccination has led to a significant reduction in the incidence of mumps in Poland.
AIM
OBJECTIVE
The aim of the study was to evaluate the epidemiological indicators of mumps in Poland in 2019 compared to previous years.
METHODS
METHODS
The analysis of the epidemiological situation of mumps in Poland in 2019 was based on the interpretation of data from the bulletin "Infectious diseases and poisonings in Poland in 2019" and "Vaccinations in Poland in 2019".
RESULTS
RESULTS
In 2019, 1,338 mumps cases were registered in Poland. The total incidence was 3.5 per 100,000 inhabitants and was lower compared to 2018. The highest incidence 4.6 per 100,000 inhabitants were registered in the Opolskie Voivodeship and the lowest - 2.5 in the Podkarpackie Voivodeship. The incidence was the highest among 6-year-olds and amounted to 32.3/100,000. Comparing the differences between the sexes, the incidence of men (4.1/100,000) was higher than that of women (2.9). In 2019, 22 patients were hospitalized due to mumps in Poland, which was less than in 2018 (28). The level of mumps vaccination in children at 3 years of age was lower by 0.3% compared to 2018 and amounted to 92.6% in Poland.
CONCLUSIONS
CONCLUSIONS
Maintaining a high percentage of children vaccinated against mumps will provide sustaining decline in cases of mumps in the coming years.
Substances chimiques
Measles-Mumps-Rubella Vaccine
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
229-234Informations de copyright
© National Institute of Public Health NIH – National Research Institute.